Lindbrook Capital’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-144
| Closed | -$14.7K | – | 2876 |
|
|
2023
Q2 | $14.7K | Sell |
144
-1
| -0.7% | -$102 | ﹤0.01% | 1250 |
|
|
2023
Q1 | $13.2K | Buy |
145
+66
| +84% | +$6K | ﹤0.01% | 1282 |
|
|
2022
Q4 | $3K | Buy |
79
+6
| +8% | +$228 | ﹤0.01% | 2054 |
|
|
2022
Q3 | $2K | Buy |
73
+24
| +49% | +$658 | ﹤0.01% | 2188 |
|
|
2022
Q2 | $1K | Buy |
49
+24
| +96% | +$490 | ﹤0.01% | 2435 |
|
|
2022
Q1 | $1K | Buy |
+25
| New | +$1K | ﹤0.01% | 2437 |
|
|
2021
Q4 | – | Sell |
-26
| Closed | -$3K | – | 2247 |
|
|
2021
Q3 | $3K | Sell |
26
-5
| -16% | -$577 | ﹤0.01% | 1469 |
|
|
2021
Q2 | $4K | Sell |
31
-18
| -37% | -$2.32K | ﹤0.01% | 1420 |
|
|
2021
Q1 | $5K | Hold |
49
| – | – | ﹤0.01% | 1288 |
|
|
2020
Q4 | $6K | Buy |
49
+29
| +145% | +$3.55K | ﹤0.01% | 1147 |
|
|
2020
Q3 | $2K | Buy |
+20
| New | +$2K | ﹤0.01% | 1469 |
|
|
2019
Q4 | – | Sell |
-400
| Closed | -$32K | – | 1574 |
|
|
2019
Q3 | $32K | Buy |
+400
| New | +$32K | 0.01% | 554 |
|
|
2019
Q2 | – | Sell |
-500
| Closed | -$42K | – | 1536 |
|
|
2019
Q1 | $42K | Sell |
500
-250
| -33% | -$21K | 0.02% | 467 |
|
|
2018
Q4 | $42K | Buy |
+750
| New | +$42K | 0.02% | 401 |
|